{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:19:37Z","timestamp":1792009177092,"version":"4.4.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"Importance<\/jats:title>Spinal cord stimulators (SCSs) are increasingly used for the treatment of chronic pain. There is a need for studies with long-term follow-up.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine the comparative effectiveness and costs of SCSs compared with conventional medical management (CMM) in a large cohort of patients with chronic pain.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This was a 1:5 propensity-matched retrospective comparative effectiveness research analysis of insured individuals from April 1, 2016, to August 31, 2018. This study used administrative claims data, including longitudinal medical and pharmacy claims, from US commercial and Medicare Advantage enrollees 18 years or older in Optum Labs Data Warehouse. Patients with incident diagnosis codes for failed back surgery syndrome, complex regional pain syndrome, chronic pain syndrome, and other chronic postsurgical back and extremity pain were included in this study. Data were analyzed from February 1, 2021, to August 31, 2022.<\/jats:p><\/jats:sec>Exposures<\/jats:title>SCSs or CMM.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Surrogate measures for primary chronic pain treatment modalities, including pharmacologic and nonpharmacologic pain interventions (epidural and facet corticosteroid injections, radiofrequency ablation, and spine surgery), as well as total costs.<\/jats:p><\/jats:sec>Results<\/jats:title>In the propensity-matched population of 7560 patients, mean (SD) age was 63.5 (12.5) years, 3080 (40.7%) were male, and 4480 (59.3%) were female. Among matched patients, during the first 12 months, patients treated with SCSs had higher odds of chronic opioid use (adjusted odds ratio [aOR], 1.14; 95% CI, 1.01-1.29) compared with patients treated with CMM but lower odds of epidural and facet corticosteroid injections (aOR, 0.44; 95% CI, 0.39-0.51), radiofrequency ablation (aOR, 0.57; 95% CI, 0.44-0.72), and spine surgery (aOR, 0.72; 95% CI, 0.61-0.85). During months 13 to 24, there was no significant difference in chronic opioid use (aOR, 1.06; 95% CI, 0.94-1.20), epidural and facet corticosteroid injections (aOR, 1.00; 95% CI, 0.87-1.14), radiofrequency ablation (aOR, 0.84; 95% CI, 0.66-1.09), or spine surgery (aOR, 0.91; 95% CI, 0.75-1.09) with SCS use compared with CMM. Overall, 226 of 1260 patients (17.9%) treated with SCS experienced SCS-related complications within 2 years, and 279 of 1260 patients (22.1%) had device revisions and\/or removals, which were not always for complications. Total costs of care in the first year were $39\u202f000 higher with SCS than CMM and similar between SCS and CMM in the second year.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this large, real-world, comparative effectiveness research study comparing SCS and CMM for chronic pain, SCS placement was not associated with a reduction in opioid use or nonpharmacologic pain interventions at 2 years. SCS was associated with higher costs, and SCS-related complications were common.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaneurol.2022.4166","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T16:32:17Z","timestamp":1669653137000},"page":"18","source":"Crossref","is-referenced-by-count":54,"title":["Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic Pain"],"prefix":"10.1001","volume":"80","author":[{"given":"Sanket S.","family":"Dhruva","sequence":"first","affiliation":[{"name":"University of California, San Francisco School of Medicine, San Francisco"},{"name":"Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco"},{"name":"Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Murillo","sequence":"additional","affiliation":[{"name":"Optum Labs, UnitedHealth Group, Eden Prairie, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Ameli","sequence":"additional","affiliation":[{"name":"Optum Center for Research and Innovation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela E.","family":"Morin","sequence":"additional","affiliation":[{"name":"Optum Labs, UnitedHealth Group, Eden Prairie, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L.","family":"Spencer","sequence":"additional","affiliation":[{"name":"Optum Labs, UnitedHealth Group, Eden Prairie, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita F.","family":"Redberg","sequence":"additional","affiliation":[{"name":"Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco"},{"name":"Department of Medicine, University of California, San Francisco School of Medicine, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Cohen","sequence":"additional","affiliation":[{"name":"Optum Center for Research and Innovation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"noi220075r1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/pme.2014.15.issue-2","article-title":"State of the field survey: spinal cord stimulator use by academic pain medicine practices.","volume":"15","author":"Gharibo","year":"2014","journal-title":"Pain Med"},{"issue":"8","key":"noi220075r2","doi-asserted-by":"publisher","first-page":"e436","DOI":"10.1097\/JOM.0000000000001933","article-title":"Increased spinal cord stimulator use and continued opioid treatment among injured workers: a regional pilot study.","volume":"62","author":"Leung","year":"2020","journal-title":"J Occup Environ Med"},{"issue":"2","key":"noi220075r5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/ner.12035","article-title":"Spinal cord stimulation as treatment for complex regional pain syndrome should be considered earlier than last resort therapy.","volume":"16","author":"Poree","year":"2013","journal-title":"Neuromodulation"},{"issue":"7","key":"noi220075r6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/M16-2459","article-title":"Nonpharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline.","volume":"166","author":"Chou","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"noi220075r8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000510775","article-title":"Trends in clinical trials for spinal cord stimulation.","volume":"99","author":"Harmsen","year":"2021","journal-title":"Stereotact Funct Neurosurg"},{"issue":"12","key":"noi220075r9","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1093\/pm\/pnz185","article-title":"Spinal cord stimulation vs conventional therapies for the treatment of chronic low back and leg pain: a systematic review of health care resource utilization and outcomes in the last decade.","volume":"20","author":"Odonkor","year":"2019","journal-title":"Pain Med"},{"key":"noi220075r10","article-title":"Implanted spinal neuromodulation interventions for chronic pain in adults.","volume":"12","author":"O\u2019Connell","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"noi220075r11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pain.2009.08.014","article-title":"Spinal cord stimulation for failed back surgery syndrome: outcomes in a workers\u2019 compensation setting.","volume":"148","author":"Turner","year":"2010","journal-title":"Pain"},{"issue":"1","key":"noi220075r12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/j.pain.0000000000001689","article-title":"Systematic review and meta-analysis of placebo\/sham controlled randomised trials of spinal cord stimulation for neuropathic pain.","volume":"161","author":"Duarte","year":"2020","journal-title":"Pain"},{"issue":"7","key":"noi220075r13","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/pm\/pny245","article-title":"Explantation of percutaneous spinal cord stimulator devices: a retrospective descriptive analysis of a single-center 15-year experience.","volume":"20","author":"Simopoulos","year":"2019","journal-title":"Pain Med"},{"issue":"9","key":"noi220075r16","doi-asserted-by":"publisher","first-page":"E531","DOI":"10.1097\/BRS.0000000000000805","article-title":"The rate of magnetic resonance imaging in patients with spinal cord stimulation.","volume":"40","author":"Desai","year":"2015","journal-title":"Spine (Phila Pa 1976)"},{"issue":"6","key":"noi220075r17","first-page":"E969","article-title":"Increasing rates of imaging in failed back surgery syndrome patients: implications for spinal cord stimulation.","volume":"20","author":"Farber","year":"2017","journal-title":"Pain Physician"},{"issue":"1","key":"noi220075r18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/ner.12370","article-title":"The incidence of spinal cord injury in implantation of percutaneous and paddle electrodes for spinal cord stimulation.","volume":"19","author":"Petraglia","year":"2016","journal-title":"Neuromodulation"},{"key":"noi220075r19","doi-asserted-by":"publisher","first-page":"k2833","DOI":"10.1136\/bmj.k2833","article-title":"Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study.","volume":"362","author":"Jeffery","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"noi220075r20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for noncancer pain.","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin J Pain"},{"issue":"6","key":"noi220075r21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.amjmed.2019.12.021","article-title":"Medication adherence, health care utilization, and spending among privately insured adults with chronic conditions in the US, 2010-2016.","volume":"133","author":"Gillespie","year":"2020","journal-title":"Am J Med"},{"issue":"11","key":"noi220075r22","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"2","key":"noi220075r24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.v10.2","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"issue":"10","key":"noi220075r25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1056\/NEJMp1406388","article-title":"Sham controls in medical device trials.","volume":"371","author":"Redberg","year":"2014","journal-title":"N Engl J Med"},{"key":"noi220075r27","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2147\/JPR","article-title":"The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis.","volume":"12","author":"Pollard","year":"2019","journal-title":"J Pain Res"},{"issue":"1","key":"noi220075r28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.45876","article-title":"Association of spinal cord stimulator implantation with persistent opioid use in patients with postlaminectomy syndrome.","volume":"5","author":"Vu","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"7","key":"noi220075r29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ner.12312","article-title":"Treatment-limiting complications of percutaneous spinal cord stimulator implants: a review of 8 years of experience from an academic center database.","volume":"18","author":"Hayek","year":"2015","journal-title":"Neuromodulation"},{"issue":"6","key":"noi220075r30","first-page":"E797","article-title":"Long-term cost utility of spinal cord stimulation in patients with failed back surgery syndrome.","volume":"20","author":"Farber","year":"2017","journal-title":"Pain Physician"},{"issue":"4","key":"noi220075r31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jpainsymman.2003.09.009","article-title":"The cost effectiveness of spinal cord stimulation in the treatment of pain: a systematic review of the literature.","volume":"27","author":"Taylor","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"noi220075r32","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/00002508-200411000-00012","article-title":"Cost benefit analysis of neurostimulation for chronic pain.","volume":"20","author":"Mekhail","year":"2004","journal-title":"Clin J Pain"},{"issue":"24","key":"noi220075r33","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1097\/BRS.0b013e31822a867c","article-title":"Costs and cost-effectiveness of spinal cord stimulation (SCS) for failed back surgery syndrome: an observational study in a workers\u2019 compensation population.","volume":"36","author":"Hollingworth","year":"2011","journal-title":"Spine (Phila Pa 1976)"},{"issue":"23","key":"noi220075r34","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1097\/01.brs.0000244618.06877.cd","article-title":"Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002.","volume":"31","author":"Deyo","year":"2006","journal-title":"Spine (Phila Pa 1976)"},{"key":"noi220075r35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2106\/00004623-200604002-00005","article-title":"Lumbar disc disorders and low-back pain: socioeconomic factors and consequences.","volume":"88","author":"Katz","year":"2006","journal-title":"J Bone Joint Surg Am"},{"issue":"7","key":"noi220075r36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.7326\/M16-2458","article-title":"Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians Clinical Practice Guideline.","volume":"166","author":"Chou","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"noi220075r37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1001\/jamainternmed.2021.7359","article-title":"Management of chronic low back pain.","volume":"182","author":"Cohen","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"7","key":"noi220075r38","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7326\/M16-2367","article-title":"Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians.","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"key":"noi220075r40","article-title":"Gradation of clinical holistic response as new composite outcome to evaluate success in spinal cord stimulation studies for pain.","author":"Goudman","year":"2021","journal-title":"Neuromodulation"},{"key":"noi220075r15","volume-title":"Optum Labs and Optum Labs Data Warehouse (OLDW) Descriptions and Citation","author":"Optum Labs"},{"key":"noi220075r3","unstructured":"US Food and Drug Administration. Conduct a trial stimulation period before implanting a spinal cord stimulator (SCS)\u2014letter to health care providers. Accessed May 20, 2022. https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/conduct-trial-stimulation-period-implanting-spinal-cord-stimulator-scs-letter-health-care-providers"},{"key":"noi220075r4","unstructured":"Global Market Insights Inc. Neurostimulation devices market value to hit $19 billion by 2025: Global Market Insights, Inc. Accessed May 20, 2022. https:\/\/www.prnewswire.com\/news-releases\/neurostimulation-devices-market-value-to-hit-19-billion-by-2025-global-market-insights-inc-300937560.html"},{"key":"noi220075r7","unstructured":"Carome? MA. Implanted spinal cord stimulators for pain relief. Accessed May 20, 2022. https:\/\/www.citizen.org\/wp-content\/uploads\/2526_200610_Spinal-Cord-Stimulator-Report_FINAL.pdf"},{"key":"noi220075r14","unstructured":"Weiss? M, Mohr? H. Spinal-cord stimulators help some patients, injure others. Accessed May 20, 2022. https:\/\/apnews.com\/article\/wv-state-wire-us-news-ap-top-news-sc-state-wire-health-86ba45b0a4ad443fad1214622d13e6cb"},{"key":"noi220075r23","unstructured":"US Centers for Medicare & Medicaid Services. Chronic conditions data warehouse. Accessed June 29, 2021. https:\/\/www2.ccwdata.org\/web\/guest\/condition-categories"},{"key":"noi220075r26","unstructured":"US Food and Drug Administration. As part of efforts to combat opioid crisis, FDA launches innovation challenge to spur development of medical devices\u2014including digital health and diagnostics\u2014that target pain, addiction, and diversion. Accessed May 20, 2022. https:\/\/www.fda.gov\/news-events\/press-announcements\/part-efforts-combat-opioid-crisis-fda-launches-innovation-challenge-spur-development-medical-devices"},{"key":"noi220075r39","unstructured":"Department of Health and Human Services Office of Inspector General. Medicare overpaid more than $636 million for neurostimulator implantation surgeries. Accessed May 20, 2022. https:\/\/oig.hhs.gov\/oas\/reports\/region1\/11800500.pdf"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2799084\/jamaneurology_dhruva_2022_oi_220075_1672852416.32954.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T16:17:02Z","timestamp":1673281022000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2799084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.4166","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}